IR Calendar

Upcoming Events

2019 Annual Meeting of Stockholders

Vancouver, Washington

2019 American Society for Microbiology (ASM) Microbe Conference

Moscone Center in San Francisco

Title: Final Results of Pivotal Study of Leronlimab (PRO 140) SC
in Heavily Treatment-Experienced HIV Patients
Presenter: Dr. Kush Dhody & Nader Pourhassan, Ph.D.
Session Title: Novel Biological Therapeutics
Session Date/Time: June 21, 2019 1:30 pm – 4:00 pm
Presentation Time: June 21, 2019 2:00 pm
Moscone Center: 201/202 South

Past Events

Investment Community Conference Call

Dial In:

877-407-2986 U.S. and Canada
201-378-4916 International

A replay of the conference call will be available until July 20, 2019. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international) and enter conference identification number 13691124.

ThinkEquity Conference
American Association of Cancer Research (AACR) Annual Meeting

Atlanta, Georgia

2019 Conference on Retroviruses and Opportunistic Infections (CROI)

Seattle, WA

CytoDyn’s Poster at CROI 2019:
Poster # 486: PRO 140 (leronlimab) SC: Long-Acting, Single-Agent Maintenance Therapy for HIV-1 Infection

  • Presenters: Drs. Kush Dhody and Nader Pourhassan
  • Date: Thursday, March 7, 2:30pm-4:00pm, Poster Hall – 4EF
Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

A replay of the conference call will be available until April 25, 2019. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international) and enter conference identification number 13683202.

BIO CEO & Investor Conference 2019

New York Marriott Marquis, 1535 Broadway, New York, NY 10036

Presentation Room: Hudson/Empire

NobleConXV Conference

The W Fort Lauderdale
401 N Fort Lauderdale Beach Blvd
Studio 1
Fort Lauderdale, FL 33304

Biotech Showcase
Singular Research "Best of the Uncovered" - Small Cap 13th Annual Conference 2018

San Francisco, CA

Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

A replay of the conference call will be available until February 12, 2019. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international) and enter conference identification number 13683202.

11th Annual LD Micro Main Event

Luxe Sunset Boulevard Hotel, Los Angeles, CA

2018 Annual Meeting of Stockholders

Hilton Portland Downtown, 921 S.W. 6th Avenue, Portland, Oregon, 97204

The MicroCap Conference

Essex House, New York, NY

Fourth Annual Robins Equity Research Roundup

Portland, OR

Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

A replay of the conference call will be available until November 13, 2018. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international) and enter conference identification number 13683202.

Singular Research Summer Solstice 2018 Conference

Convene Conference Center, New York, NY

Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

A replay of the conference call will be available until September 17, 2018. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international) and enter conference identification number 13672522.

ASM Microbe 2018

Georgia World Congress Center - Atlanta, GA

Special Meeting of Stockholders

One Lowenstein Drive, Roseland, New Jersey 07068

9:30 am ET

Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

2017 Annual Meeting of Stockholders

Proxy Statement

7th Annual LD Micro Invitational

Luxe Sunset Boulevard Hotel, Los Angeles

Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

CytoDyn Presentations at
CROI 2017
Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

LD Micro Main Event

Luxe Sunset Hotel, Los Angeles, CA

CytoDyn Investment Community Presentation

The presentation by Dr. Nader Pourhassan, President and CEO, addressed previous public disclosures regarding CytoDyn's Phase 3 combination therapy trial protocol modifications and timelines for other initiatives.

CytoDyn Investment Community Call to Discuss Phase 3 Trial Protocol Modifications and Other Updates
Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).
Rodman & Renshaw 18th Annual Global Investment Conference

Lotte New York Palace Hotel, New York City

2016 Annual Meeting of Stockholders

Hilton Vancouver Washington

Click here to view proxy material for Annual Meeting.

CytoDyn Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

CytoDyn Investment Community Conference Call
ASM Microbe Conference

PRO 140 SC Monotherapy provides long-term full virologic suppression in HIV patients
Presented by: Paul J. Maddon, MD, Ph.D.
Click here for presentation

LD Micro Invitational Conference

Luxe Sunset Bel Air Hotel, Los Angeles, CA

Click the webcast link below for an audio and video replay of CytoDyn's presentation.

Interview with the CEO

Stock News Now Interview of Nader Pourhassan, President & CEO of CytoDyn at LD Micro Invitational Conference

Click here for interview

CytoDyn Investment Community Conference Call
CytoDyn Investment Community Conference Call
CytoDyn Investment Community Conference Call
CytoDyn Investment Community Conference Call
Investment Community Update
CytoDyn Investment Community Call to Discuss Today's Submission of Phase 3 Protocol to FDA and Upcoming Plans
CytoDyn Investment Community Call to Discuss Interim Results from its Treatment Substitution Study in Patients with HIV
2014 Annual Shareholder Meeting
CytoDyn Investment Community Conference Call
Investor Update Conference Call
Investor Update Conference Call
31st Annual J.P. Morgan Healthcare Conference